Shaily Engineering Plastics Limited has informed the Exchange about Investor Presentation
SEPL/SE/AUG/25-26 11th August 2025
The General Manager, Corporate Relations/Listing Department BSE Limited Floor 25, P.J. Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 501423
The Manager, Listing Department National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Bandra – Kurla Complex, Bandra (E), Mumbai – 400 051 Scrip Code: SHAILY
Sub: Q1FY26 - Result Presentation
Ref:
Regulation 30 of the SEBI Listing Regulations, 2015
Dear Sir,
In continuation to our letter dated 06th August 2025, regarding intimation of Earnings Call of the Company scheduled on Monday, 11th August 2025 at 05:00 p.m., to discuss the operational & financial performance of the Company for the quarter ended on 30th June 2025, kindly find enclosed herewith Q1FY26 Result Presentation of the Company.
A copy of the same is also available on our website www.shaily.com.
Thanking You.
Yours truly, For Shaily Engineering Plastics Limited
Harish Punwani Company Secretary & Compliance Officer M. No. A 50950
Encl: a/a
Shaily Engineering Plastics Ltd
Investors Presentation August 2025
Safe Harbor
This presentation and the accompanying slides (the “Presentation”), which have been prepared by Shaily Engineering Plastics Limited (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company.
This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this Presentation. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded.
Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third party statements and projections.
2
Key Performance Highlights
Business Updates for Q1 FY26
Healthcare
19 injection moulding machines are under In response to rising installation in response to customer demand for GLP- customer demand, with 1 drugs completion expected by Q2 FY26
Installation of Plant & Machinery supplied by customer for the manufacture of
Eye Applicators under way
Contract signed for the In response to rising Supply of Pens for customer demand for GLP- 1 drugs GLP-1
Consumer
Order received for mixed material product
Awarded Business for Male Accessories from marquee FMCG customer
4
Key Financial Highlights – Q1FY26 (Consolidated*)
Revenues
Gross Profit Margin
+38%
246.7
179.4
+910 bps
51.2%
42.1%
EBITDA
+95%
70.4
36.1
Q1FY25
Q1FY26
Q1FY25
Q1FY26
Q1FY25
Q1FY26
EBITDA Margins
Profit After Tax
+840 bps
28.5%
20.1%
+136%
41.1
Cash PAT#
+91%
52.6
17.4
27.6
(Rs. Cr.)
Q1FY25
Q1FY26
Q1FY25
Q1FY26
Q1FY25
Q1FY26
#Cash PAT includes PAT & Depreciation
* Includes the UK & UAE Subsidiary Business
5
Segment Wise Revenue Breakup
Revenue (Consumer)
Revenue (Healthcare)
Revenue (Industrial)
TOTAL REVENUE
14% YoY
151.4
132.8
181% YoY
77.2
19.2
-6% YoY
18.1
38% YoY
246.7
179.4
27.4
Q1FY25
Q1FY26
Q1FY25
Q1FY26
Q1FY25
Q1FY26
Q1FY25
Q1FY26
Improved traction in the healthcare segment has been the key driver for the overall growth of the business
On Consolidated Basis
6
Key Financial Highlights – Q1FY26 (Standalone)
Revenues
+33%
225.1
169.0
Gross Profit Margin
+1,140 bps
50.0%
38.6%
EBITDA
+125%
62.7
27.9
Q1FY25
Q1FY26
Q1FY25
Q1FY26
Q1FY25
Q1FY26
EBITDA Margins
Profit After Tax
+1,140 bps
27.9%
+268%
36.0
Cash PAT#
+141%
46.6
16.5%
9.8
19.3
(Rs. Cr.)
Q1FY25
Q1FY26
Q1FY25
Q1FY26
Q1FY25
Q1FY26
#Cash PAT includes PAT & Depreciation
7
Operational Trends
n o i t a z i l i t U e n h c a M
i
)
%
(
l
s t n a P s s o r c A
s r e m y l o P f o e m u o V
l
) T M
( d e s s e c o r P
+940 bps
48.7%
39.3%
Q1FY25
Q1FY26
+18.9%
7,016
5,902
Q1FY25
Q1FY26
Revenue Analysis – Domestic vs. Exports
Q1 FY25
vs
Q1 FY26
20.1%
23.9%
79.9%
76.1%
8
Efficient Use of Capital
RoCE
RoE
Fixed Asset Turnover
Total Debt / Equity
+1,610 bps
40.5%
+1,230 bps
30.8%
2.1
0.4
24.4%
18.5%
1.7
0.3
Mar-25
Jun-25
Mar-25
Jun-25
Mar-25
Jun-25
Mar-25
Jun-25
On Consolidated Basis
9
Profit & Loss Statement
Particulars (Rs. Cr.)
Revenue
Raw Material
Employee Expenses
Other Expenses*
Other Income
EBITDA
EBITDA Margin
Depreciation
Finance Cost
PBT
PBT Margin
Tax
PAT
PAT Margin
Cash PAT^
Cash PAT Margin
Consolidated
Standalone
Q1 FY26
Q1 FY25
246.7
120.5
24.9
33.0
2.1
70.4
28.5%
11.4
3.9
55.1
22.3%
14.0
41.1
16.7%
52.6
21.3%
179.4
103.9
17.9
22.2
0.7
36.1
20.1%
10.1
4.4
21.6
12.1%
4.2
17.4
9.7%
27.6
15.4%
YoY %
+38%
+95%
+155%
+136%
+91%
Q1 FY26
Q1 FY25
225.1
112.5
20.6
31.3
2.1
62.7
27.9%
10.6
3.9
48.3
21.4%
12.3
36.0
16.0%
46.6
20.7%
169.0
103.9
17.7
20.9
1.4
27.9
16.5%
9.6
4.4
14.0
8.3%
4.2
9.8
5.8%
19.3
11.4%
YoY %
+33%
+125%
+245%
+268%
+141%
* Other Expenses include Power & Fuel costs
^ Cash PAT = PAT + Depreciation
10
About the Company
Enriching Lives Through Plastics
Shaily Engineering Plastics Limited is India’s largest exporter of plastics components. Established in 1987, the Company provides end-to-end solutions in plastic products and services, whilst delivering superior quality and value to all stakeholders. The Company employs over 2,000+ employees and have over 200+ injection molding machines, with precise, high speed automated and robotic production lines.
Founded in 1987
Revenue* Rs. 787 Crores FY 25
7 Facilities in Gujarat 6 for Plastic 1 for Steel Furniture
Long-standing global relationships with marquee clients
200+ Injection moulding machines
Over 2,000 employees across 7 plants
De-risked Business Model
On Consolidated Basis
11
Business Segments
Consumer
Industrial
Healthcare
✓ Home Furnishings
✓ FMCG Packaging
✓ LED Lights
✓ Toys
✓ Carbon Steel Furniture
✓ Automotive Components
✓ Appliances
✓ High Performance Engineering Components
✓ Platform Devices
✓ Drug Delivery Devices
✓ Pharma Packaging
12
State-of-the-Art Manufacturing Facilities
7 Facilities with over 200 molding machines ranging from 35 tons to 1,000 tons
Rania
Halol
GUJARAT
Rania
❖ Export Oriented Unit ❖ Pharma (Dedicated ISO Class 8 clean
room manufacturing facility)
❖ Others
Halol (GIDC)
❖ Automotive & Engineering
Halol
❖ Carbon Steel ❖ Plastic
Disclaimer: Maps not to scale. All data, information, and maps are provided "as is" without warranty or any representation of accuracy, timeliness or completeness.
13
Board of Directors
Executive Chairman
Mr. Mahendra Sanghvi
Whole Time Director
Ms. Tilottama Sanghvi
Managing Director
Mr. Amit Sanghvi
Executive Director
Mr. Laxman Sanghvi
Independent Director
Dr. Shailesh Ayyangar
Independent Director
Mr. Ranjit Singh
Independent Director
Mr. Samaresh Parida
Independent Director
Mrs. Sangeeta Singh
14
Strong Credit Rating*
LONG TERM BANK FACILITIES
Rs. 238.45 Crs.
CARE A+ ; Outlook: Stable
Rating Action: Upgraded
SHORT TERM BANK FACILITIES
Rs. 35 Crs.
CARE A1
Rating Action: Reaffirmed
Long and established track record in the plastic injection molding business along with experienced Promoters
Growth in Total operating income on the back of increased volumes & higher exports
Sustainable healthy operating margin along with strengthening leverage and debt coverage indicators
New business confirmations from existing clients along with addition of marquee clients across diversified industries
Sustainable healthy operating margin along with strengthening leverage and debt coverage indicators
*Updated as on 31st March 2025
15
Historical Profit & Loss Statement
Particulars (Rs. Cr.)
Revenue
Raw Material
Employee Expenses
Other Expenses*
Other Income
EBITDA
EBITDA Margin
Depreciation
Finance Cost
PBT
PBT Margin
Tax
PAT
PAT Margin
Cash PAT^
Cash PAT Margin
Consolidated
Standalone
FY25
786.8
415.8
80.4
114.5
2.3
178.4
22.7%
42.2
16.9
119.3
15.2%
26.2
93.1
11.8%
135.3
17.2%
FY24
643.9
370.1
57.3
99.5
6.5
123.4
19.2%
35.7
17.9
69.8
10.8%
12.6
57.3
8.9%
93.0
14.4%
FY23
607.1
386.5
47.9
80.8
4.5
96.4
15.9%
33.3
17.9
45.2
7.4%
10.1
35.1
5.8%
68.5
11.3%
FY25
738.1
415.7
72.8
106.0
7.4
151.0
20.5%
39.4
16.9
94.7
12.8%
23.7
70.9
9.6%
110.3
14.9%
FY24
616.0
370.1
55.9
95.2
6.5
101.3
16.4%
34.7
17.9
48.7
7.9%
12.6
36.1
5.9%
70.8
FY23
599.7
386.5
47.2
79.4
4.5
91.1
15.2%
33.2
17.9
40.1
6.7%
10.1
30.0
5.0%
63.2
11.5%
10.5%
* Other Expenses include Power & Fuel costs
^ Cash PAT = PAT + Depreciation
16
Historical Balance Sheet
Particulars Non-Current assets Property, Plant and Equipments Capital Work in Process Intangible assets Investments Intangible assets under development Financial Assets Loans Other Non-Current Assets Income tax assets Total Non-Current Assets Current Assets Inventories Financial Assets Trade Receivables Cash and Cash Equivalents Loans Other Current Assets Current tax assets (Net) Total Current Assets Total Assets
Mar-25
Mar-24
Mar-23
459.1 17.4 42.1 - 0.3
0.5 23.9 3.8 547.0
435.4 15.3 38.0 0.0 5.1
0.5 18.3 2.7 515.3
347.9 49.0 19.0 0.0 19.3
0.5 17.2 2.1 455.0
137.8
83.6
73.0
171.7 23.1 0.3 52.6 - 385.6 932.6
117.4 26.4 6.4 33.5 0.0 267.2 782.5
91.9 23.0 5.7 44.1 0.0 237.7 692.7
Particulars Equity Equity Share Capital Other Equity
Total Equity Non-Current Liabilities Financial Liabilities Long-term borrowings Deferred tax liabilities (net) Other long-term liabilities Long-term provisions
Total Non-Current Liabilities Current Liabilities Short-term borrowings Trade payables Other financial liabilities Other current liabilities Short-term provisions Current tax liabilities (net) Total Current Liabilities
Total Equity and Liabilities
Mar-25
Mar-24
Mar-23
9.2 538.5
547.7
40.1 23.6 0.2 3.9
67.8
147.6 99.0 12.5 44.0 7.1 6.9 317.1
932.6
9.2 450.0
459.2
69.8 20.8 1.2 2.2
94.1
138.5 68.7 10.3 10.4 1.3 0.0 229.2
782.5
9.2 392.2
401.4
62.5 17.0 1.2 2.3
83.1
124.3 53.4 9.3 20.0 1.2 0.0 208.2
692.7
On Consolidated basis
17
Historical Balance Sheet
Particulars Non-Current assets Property, Plant and Equipments Capital Work in Process Intangible assets Investments Intangible assets under development Financial Assets Loans Other Non-Current Assets Income tax assets Total Non-Current Assets Current Assets Inventories Financial Assets Trade Receivables Cash and Cash Equivalents Loans Other Current Assets Current tax assets (Net) Total Current Assets Total Assets
Mar-25
Mar-24
Mar-23
457.6 17.4 19.5 11.3 0.3
0.5 23.9 1.5 532.0
434.9 15.3 17.8 20.6 2.1
0.5 18.3 2.3 511.8
348.6 49.0 13.8 15.4 5.7
0.5 17.2 2.1 452.3
137.8
83.6
73.0
148.1 8.5 0.3 44.0 - 338.7 870.6
111.7 8.6 6.4 29.9 0.0 240.3 752.1
88.8 17.7 13.7 39.2 0.0 232.4 684.6
Particulars Equity Equity Share Capital Other Equity
Total Equity Non-Current Liabilities Financial Liabilities Long-term borrowings Deferred tax liabilities (net) Other long-term liabilities Long-term provisions
Total Non-Current Liabilities Current Liabilities Short-term borrowings Trade payables Other financial liabilities Other current liabilities Short-term provisions Current tax liabilities (net) Total Current Liabilities
Total Equity and Liabilities
Mar-25
Mar-24
Mar-23
9.2 487.0
496.2
40.1 22.6 0.2 3.9
66.8
147.6 97.9 12.5 38.0 7.1 4.4 307.6
870.6
9.2 422.3
431.5
69.8 20.4 1.2 2.2
93.6
138.5 67.2 10.3 9.7 1.3 0.0 227.0
752.1
9.2 386.5
395.6
62.5 16.9 1.2 2.3
82.9
123.2 51.7 10.4 19.5 1.2 0.0 206.1
684.6
On Standalone basis
18
Cash Flow Statement
Consolidated
Standalone
Particulars (Rs. Cr.)
Profit Before Tax
Adjustments
Operating profit before working capital changes
Changes in working capital
Cash generated from operations
Direct taxes paid (net of refund)
Net Cash from Operating Activities
Net Cash from Investing Activities
Net Cash from Financing Activities
Net Change in cash and cash equivalents
Add: Cash & Cash equivalents at the beginning of the period
Closing Cash Balance
FY25
119.3
56.6
175.9
-48.3
127.6
-17.5
110.1
-71.3
-41.9
-3.1
22.2
19.1
FY24
69.8
58.2
128.0
-27.0
101.0
-8.8
92.3
-99.0
9.8
3.1
19.1
22.2
FY23
45.2
51.4
96.6
-0.6
96.0
-6.0
90.0
-100.9
-5.1
-16.0
35.1
19.1
FY25
94.7
46.6
141.3
-30.5
110.7
-15.1
95.6
-53.7
-41.9
0.0
4.4
4.4
FY24
48.7
56.2
104.8
-21.6
83.3
-8.8
74.5
-92.4
4.6
-13.3
17.7
4.4
FY23
40.1
50.4
90.5
0.2
90.7
-6.0
84.7
-93.3
-5.1
-13.7
31.4
17.7
19
Contact
Company :
Investor Relations Advisors :
Shaily Engineering Plastics Ltd. CIN – L51900GJ1980PLC065554
Mr. Sanjay Shah, Chief Strategy Officer sanjay@shaily.com
www.shaily.com
Strategic Growth Advisors Pvt. Ltd. CIN - U74140MH2010PTC204285
Mr. Shogun Jain / Mr. Deven Dhruva shogun.jain@sgapl.net / deven.dhruva@sgapl.net +91 77383 77756 / +91 98333 73300 www.sgapl.net
20